ReviewFrontiers in neurology2020
Non-pharmacological Treatment Challenges in Early Parkinson's Disease for Axial and Cognitive Symptoms: A Mini Review.
Review in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Curcumin as a potential therapeutic agent for Parkinson's disease: a systematic review.Frontiers in pharmacology · 2025Pooled it
- Climb up! Head up! Climbing improves posture in Parkinson's disease. A secondary analysis from a randomized controlled trial.Clinical rehabilitation · 2023Trial
- Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease.Parkinsonism & related disorders · 2023Trial
- Development, validity, and reliability of the Parkinson's voice and speech handicap index (PaVSHI).Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- Intensive multidisciplinary rehabilitation modulates serumFrontiers in cellular neuroscience · 2026Article
- Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohort.NPJ Parkinson's disease · 2025Article
- Is self-perception related to speech perceptual analysis measures in early- and late-onset Parkinson's disease?Dementia & neuropsychologia · 2025Article
- The feasibility of a visuo-cognitive training intervention using a mobile application and exercise with stroboscopic glasses in Parkinson's: Findings from a pilot randomised controlled trial.PLOS digital health · 2024Article
- The Role of Non-Invasive Brain Modulation in Identifying Disease Biomarkers for Diagnostic and Therapeutic Purposes in Parkinsonism.Brain sciences · 2024Review
- Article
- Pathophysiology and Neuroimmune Interactions Underlying Parkinson's Disease and Traumatic Brain Injury.International journal of molecular sciences · 2023Review
- Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.Revista de neurologia · 2022Review
- Effectiveness of Nintendo Wii on Balance in People with Parkinson's Disease: A Systematic Review.Journal of lifestyle medicine · 2022Review
- Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson's disease.NPJ Parkinson's disease · 2021Article
- Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic: A Feasibility Study.Frontiers in neurology · 2021Article
- Speech Characteristics Across Motor Subtypes of Parkinson's Disease.International journal of language & communication disordersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.